Revenue: The sum of all revenue fields included for a company's operating activities.
Artiva Biotherapeutics, Inc. (ARTV) had Revenue of $0.25M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$0.25M |
$-65.37M |
|
-- |
|
$0.25M |
|
$67.53M |
|
$-67.28M |
|
$1.91M |
|
$-65.37M |
|
$-65.37M |
|
$-65.37M |
|
$-65.37M |
|
$-65.37M |
|
$-65.37M |
|
$-67.28M |
|
$-64.85M |
|
11.26M |
|
11.26M |
|
$-5.81 |
|
$-5.81 |
|
| Balance Sheet Financials | |
$188.63M |
|
$6.37M |
|
$20.95M |
|
$209.58M |
|
$12.25M |
|
$0.04M |
|
$10.69M |
|
$22.94M |
|
$186.64M |
|
$186.64M |
|
$186.64M |
|
24.29M |
|
| Cash Flow Statement Financials | |
$-55.03M |
|
$-120.46M |
|
$162.23M |
|
$53.76M |
|
$40.49M |
|
$-13.27M |
|
$6.98M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.39 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
100.00% |
|
-26805.58% |
|
-26805.58% |
|
-25837.05% |
|
-26045.02% |
|
-26045.02% |
|
$-55.67M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
1.72 |
|
212.31 |
|
-35.03% |
|
-35.03% |
|
-31.19% |
|
-35.02% |
|
$7.68 |
|
$-4.94 |
|
$-4.89 |
|